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Abstract
Motivation: There is a growing need to integrate mechanistic models of biological processes with
computational methods in healthcare in order to improve prediction. We apply data assimilation in the
context of Type 2 diabetes to understand parameters associated with the disease.
Results: The data assimilation method captures how well patients improve glucose tolerance after their
surgery. Data assimilation has the potential to improve phenotyping in Type 2 diabetes.
Contact: hripcsak@columbia.edu
1 Introduction
There is a growing need to integrate mechanistic models of
biological processes with computational methods in healthcare.
Popular computational methods, such as machine learning, are
useful for predicting outcomes of interest, yet are limited in
settings with sparse, irregular, and inaccurate data. Adding
mechanistic models to machine learning methods aims to boost
the power of the analyses by adding physiological constraints and
minimizing the data required.
Data assimilation (Law et al., 2015) combines mechanistic
models with data using Bayesian statistics to make forecasts.
Data assimilation (DA) has been successfully employed in
diverse fields including the geosciences (Carrassi et al., 2018) and
biomedicine (Tang et al., 2018). We build upon previous work
(Albers et al., 2017) and (Albers et al., 2018) that applies data
assimilation in the context of Type 2 diabetes. Albers et al. (2017)
discussed how data assimilation could be used to forecast future
glucose values, to impute previously missing glucose values,
and to infer Type 2 diabetes phenotypes. Albers et al. (2018)
showed that data assimilation forecasts comparewellwith specific
glucose measurements and match or exceed in accuracy expert
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forecasts. These findings could be of potential use for diabetes
self-management. We are interested in using data assimilation to
improve phenotyping in Type 2 diabetes.
We use oral glucose tolerance tests (OGTTs) to demonstrate
how data assimilation could be used to estimate the parameters of
a model of glucose and insulin dynamics. OGTTs are commonly
used to diagnose diabetes and can also identify patients with
impaired glucose tolerance. OGTT data can be found in an
electronic medical record and can be compared between patients
and studied over time. We would like to study the differences
in parameter patterns between patients with normal glucose,
glucose intolerance, and diabetes using the lab results of OGTTs.
Better understanding of a patientâŁ™s underlying physiological
parameters could in principle lead to better understanding of
diabetes and eventually better treatments.
2 Materials
We created a dataset of OGTTs for each patient using the
electronic medical record at Columbia University. We first
pulled together all of the laboratory tests related to glucose
measurements that could be relevant to OGTTs. We selected only
male patients to avoidmeasuring parameters related to gestational
diabetes. We selected all male patients that had at least two dates
of glucose measurements and at least three glucose measurements
per date. We kept all glucose measurements that appeared to be
related to OGTTs. We also pulled together all of the laboratory
tests related to insulin measurements that occurred on the same
dates as the glucose measurements. This initial dataset resulted in
200 male patients out of 564750 male patients with glucose data.
Out of the 200 patients, we kept glucose measurements that
occurred at the regularly expected times of an OGTT, which are
combinations of fasting, 30 minute, 1 hour, 1.5 hour, 2 hour, 3
hour, 4 hour, 5 hour, and 6 hour. The most frequent combinations
were fasting, 30 minute, 2 hour, and fasting, 60 minute, and 2
hour. We assumed that at these times, the patients received 75
grams of glucose after taking a fasting glucose measurement. We
kept the insulin measurements that occurred at the timepoints of
the glucose measurements. We removed patients that had glucose
measurements that were not consistent with OGTTs, had repeated
measurements, or were missing glucose measurements. We kept
patients that had missing insulin measurements as long as they
had complete glucose measurements. We kept patients that had
at least two OGTTs. As a result of these conditions, we had a
dataset of 147 patients that we used for the analysis. We collected
any hemoglobin A1C (HbA1c) data that were available for these
patients.
3 Methods
Data assimilation (DA) is a method that combines models with
data to reconstruct the model state and provide forecasts. We use
a longitudinal mathematical model described in Ha and Sherman
(2019) that is capable of representing the metabolic state of an
individual at any point in time during their progression from
normal glucose tolerance toType 2 diabetes over a period of years.
We aim to reconstruct the parameters relevant to glucose-insulin
dynamics from the oral glucose tolerance test measurements of
patients using the mathematical model.
We solve seven ordinary differential equations (ODE) in the
data assimilator. We use the built-in MATLAB solver, ode45, to
solve these equations. These ODEs are displayed in Equations 1
– 7. Please review Ha and Sherman (2019) for more details on
the equations.
dG
dt
=MEAL+HGP − (EGO + SII)G (1)
dI
dt
=
β
V
ISR− kI (2)
ISR = σ
(M + γ)kISR
αkISR
ISR
(M + γ)kISR
(3)
M =
GkM
αkM
M
+GkM
(4)
dγ
dt
=
γ∞(G)γ
τγ
(5)
dσ
dt
=
σ∞(ISR,M)− σ
τσ
(6)
dβ
dt
=
(P (ISR)− A(M))β)
τβ
(7)
Equation 1 is the glucose (G) equation. It says that G
increases as a result of meal influx (MEAL) and hepatic
glucose production (HGP ) and decreases as a result of uptake.
The parameter I represents insulin and SI represents insulin
sensitivity. The parameter EGO represents disposal.
Equation 2 is the insulin I equation. It says that I decreases
due to removal with rate constant k and increases due to secretion
by beta cells, where β is the beta-cell mass, described in Equation
7. ISR is the insulin secretion rate described in Equation 3 and
V is the volume of distribution.
Equation 3 describes further the insulin secretion rate (ISR).
The value M represents beta-cell metabolism and is described
further in Equation 4. The parameter γ represents the effect
of K(ATP) channel density to shift the glucose dependence of
secretion. The parameter σ represents insulin secretion, described
further in Equation 6.
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Equation 4 describes beta-cell metabolism, M , where M is
assumed to be a sigmoidally-increasing function of G.
Equation 5 describes the parameter γ, where γ∞ is an
increasing sigmoidal function of G, and τγ is the time constant.
Equation 6 describes beta-cell functional compensationwhere
it is assumed that increased ISR leads to an increase inσwhereas
increasedM leads to a decrease in σ.
Equation 7 describes increased beta-cell mass, β. It is
assumed β is increased by proliferation, P , and decreased by
apoptosis, A.
We estimate two parameters, σ, (sigma) and SI
(SI), combining deterministic optimization using interior-point
methods with stochastic optimization using Monte Carlo Markov
chain (MCMC). Specifically we use deterministic methods to
quickly survey the solution surface to set both initial values
and prior boundaries for the sigma and SI parameters for the
MCMC. The final estimation of parameters and the uncertainty
quantification of those estimates is calculated using the standard
formulation of random walk Metropolis Hastings algorithm
(Metropolis et al., 1953). Each patient is estimated using three
MCMC chains run with 10000 iterations. We choose the
parameter estimates using the chain that minimized the mean
squared error. The MCMC proposal step size coefficient was
0.1 for all parameters. The sigma and SI parameters had good
convergence of the chains as seen in Figure 1.
We apply upper and lower boundaries to estimate the
parameters. We use 0 < sigma < 5000 and 0 < SI < 5.
All of the other parameters in the ODE equations were set to
nominal values, values that have been reported in the literature.
We consider the effect of insulin on the results by running the data
assimilation with and without insulin.
4 Results
We reviewed the medical histories of nine of the 147 patients
that were run in the data assimilation. We were interested to
learn if their histories coincided with the parameters that were
being estimated in the model. We used the guidelines of the
National Institute of Diabetes and Digestive and Kidney Diseases
(Association, 2016) and (Bergman et al., 2018) to determine
whether the OGTT was normal, impaired glucose (prediabetes)
or diabetes. Since we collected HbA1c data, we also reviewed the
disease states as determined by the HbA1c value, which is also
detailed in (Association, 2016). We show in Tables 1 – 2 the test
numbers that are needed for each diagnosis.
For the analysis, we calculated average values for the sigma,
SI, and sigma * SI parameters. We used a burnin of 5000 for each
of the three chains and averaged the remaining iterations across
the chains for each parameter.
We found that overall, for these nine patients, there was clear
separation between the parameters, sigma, SI, and sigma*SI, and
disease, when including and excluding insulin. In addition, the
Fig. 1: Example of a Diagnostic Plot of Three Chains for Sigma
and SI
Diagnosis Fasting 1 Hour Glucose 2 Hour Glucose
Normal 99 or below 154 or below 139 or below
Impaired Glucose 100 to 125 155 and above 140 to 199
Diabetes 126 or above 200 or above
Table 1. Diagnosing Diabetes using the Oral Glucose Tolerance Test
Diagnosis A1C Level
Normal below 5.7 percent
Impaired Glucose 5.7 to 6.4 percent
Diabetes 6.5 percent or above
Table 2. Diagnosing Diabetes using the A1C Test
values for the parameters are generally higher for normal glucose
and lower for impaired and diabetic glucose.
In particular, we consider the results of the nine patients
when including insulin. For the sigma parameter, there were four
patients that had separation and for those patients, the values
for the sigma parameter was higher for the normal glucose than
for the impaired and diabetic glucose. Two patients did not have
clear separation of the parameter and three patients did not have
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at least two disease levels to tell if there was separation. For the
SI parameter, there were five patients that had separation of the
parameter. For three of these cases, the values for the SI parameter
for the normal glucose was lower than the values for the impaired
and diabetic glucose. In the other two cases, the values for the SI
parameter for the normal glucose was higher than the impaired
and diabetic glucose. There was one patient that did not have
clear separation and three patients did not have at least two disease
levels to tell if there was separation. For the sigma * SI parameter,
therewere six patients with clear separation of the parameters. For
those patients, the values for the sigma*SI parameter was higher
for the normal glucose than for the impaired and diabetic glucose.
For the other three patients, they did not have at least two disease
levels to tell if there was separation.
We consider the results of the nine patients when not including
insulin. For the sigma parameter, there were four patients that
separation, and for those patients, two patients had values for the
sigma parameter that was higher for the normal glucose than the
impaired and diabetic glucose, and two patients had values for
the sigma parameter that was lower for the normal glucose than
the impaired and diabetic glucose. Three patients did not have
clear separation of the parameter and two patients did not have at
least two disease levels to tell if there was separation. For the SI
parameter, there were seven patients that had separation. For all
seven patients, the values for the SI parameter were higher for the
normal glucose than for the impaired and diabetic glucose. Two
patients did not have at least two disease levels to tell if there was
separation. For the sigma * SI parameter, there were six patients
that had separation. For those patients, the values for the sigma
* SI parameter were higher for the normal glucose than for the
impaired and diabetic glucose. One patient did not have clear
separation of the parameter and two patients did not have at least
two disease levels to tell if there was separation.
Figure 2 is a sample patient, Patient 1, from the nine patients,
that displays the sigma, SI, and sigma * SI parameter values,
with and without insulin, for each OGTT. This patient had eight
OGTTs, ordered fromTestNumber0 toTestNumber7. Thesigma
parameter does not have clear separation, with or without insulin,
and the SI parameter with insulin does not have clear separation.
The SI parameter without insulin and the sigma * SI parameter,
with and without insulin, has clear separation of values between
normal and impaired glucose. Figures 3 – 11 show sigma * SI
parameter values, without insulin, for the nine patients of which
we reviewed their medical histories.
For Figure 3, for Patient 1, there is clear separation of the
sigma * SI parameter values, without insulin, between normal
and impaired glucose. The sigma * SI values are higher for the
normal glucose than for the impaired glucose. Patient 1 had a
gastric band in 2009, and at the next OGTT which occurred in
2009, the sigma * SI improved. The improvement is indicated by
Fig. 2: Scatterplots of Parameters by Test Number
Fig. 3: Scatterplots of HbA1c and Sigma * SI by Year
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Fig. 4: Scatterplots of HbA1c and Sigma * SI by Year
Fig. 5: Scatterplots of HbA1c and Sigma * SI by Year
the higher green value for 2009 in the Figure 3. The sigma * SI
also improved after the second impaired glucose tolerance result
which occurred 2012. The HbA1c values for Patient 1 were either
normal or impaired glucose.
Fig. 6: Scatterplots of HbA1c and Sigma * SI by Year
Fig. 7: Scatterplot of Parameters and HbA1c by Year
For Figure 4, for Patient Number 2, there is clear separation of
the sigma * SI parameters, without insulin. The sigma * SI values
are higher for the normal glucose than for the diabetic glucose.
The HbA1cs were either impaired or diabetic glucose.
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Fig. 8: Scatterplot of Parameters and HbA1c by Year
Fig. 9: Scatterplots of HbA1c and Sigma * SI by Year
For Figure 5, for PatientNumber 3, there is no clear separation
because the OGTTs results only showed impaired glucose
tolerance. Also, this patient did not have insulin measurements.
The HbA1cs were normal, impaired, and diabetic glucose.
Fig. 10: Scatterplot of Parameters and HbA1c by Year
Fig. 11: Scatterplots of HbA1c and Sigma * SI by Year
For Figure 6, for Patient Number 4, there clear separation of
sigma * SI, without insulin. The sigma * SI values are higher for
the normal glucose than for the impaired glucose. The HbA1cs
are all normal glucose.
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For Figure 7, for Patient Number 5, there clear separation of
sigma * SI, without insulin. The sigma * SI values are higher for
the normal glucose than for the impaired glucose. The HbA1c
values were either normal or impaired glucose.
For Figure 8, for Patient Number 6, there clear separation of
sigma * SI, without insulin. The sigma * SI values are higher for
the normal glucose than for the impaired glucose. The HbA1c
values were either normal or impaired glucose.
For Figure 9, for Patient Number 7, we are unable to tell if
there is separation of the sigma * SI parameters, without insulin,
because there is a sigma * SI value for the normal glucose that
is lower than the impaired glucose. This patient had an impaired
glucose tolerance result and subsequently, a gastric band in 2006.
After the gastric band, the patient had a normal glucose result in
2006 and an improved sigma * SI value, as evident by the higher
green value in the graph for the year 2006. The HbA1c values
were normal or impaired glucose.
For Figure 10, for Patient Number 8, there clear separation of
sigma * SI, without insulin. The sigma * SI values are higher for
the normal glucose than for the impaired glucose. This patient had
a band fix in 2008 and bariatric surgery in 2010. After the band fix,
the sigma * SI improved and in the year of the bariatric surgery,
the sigma * SI remained high. The HA1c values are normal or
impaired glucose.
Lastly, for Figure 11, for Patient Number 9, we are unable to
tell if there is separation of the sigma * SI parameter since all of
the OGTTs were normal glucose. This patient had a gastric band
in 2011 and afterwards, the sigma * SI parameter improved every
OGTT afterwards.
In the Appendix, we placed the Figures 18 – 26 for the with
insulin case of the nine patients. These figures show the sigma *
SI parameter values and the HbA1c values in the year that they
occurred. The separation results are similar to the without insulin
cases.
Thus, considering gastric related surgeries, such as the gastric
band, gastric band fix, and bariatric surgery, the sigma * SI
improves after one to two OGTTs. In addition, there appears to be
clear separation of sigma * SI for normal, impaired glucose, and
diabetic glucose, with and without insulin. Generally, the sigma *
SI values are higher for the normal glucose than for the impaired
and diabetic glucose.
We used a quantitative analysis to review the results for
all of the patients. Since there appear to be differences in the
parameters given the inclusion or exclusion of insulin, we wish
to compare the change in sigma, the change in SI, and the change
in sigma * SI and determine the parameter that is the most
robust to the change. There were 124 patients with OGTTs that
had both glucose and insulin, so we used those patients for the
comparison. We standardized the dataset by scaling and centering
the parameters in order to compare the parameters to each other
Parameter Mean Standard Error 95% Confidence Interval
Sigma 0.6254 0.0015 [0.6224, 0.6284]
SI 0.8411 0.0020 [0.8371, 0.8451]
Sigma * SI 0.0868 0.0002 [0.0864, 0.0872]
Table 3. Statistics for the Bootstrap Distributions
meaningfully. Since we are interested in differences, we create a
new variable of interest, the absolute value of the difference, for
sigma, SI, and sigma * SI. Specifically, we calculated the absolute
value of the difference of sigma with and without insulin, of SI
with and without insulin, and of sigma * SI with and without
insulin. We used a clustered bootstrap to draw the samples for
each of these variables of interest. We clustered the bootstrap
since each patient could have multiple OGTTs. To cluster, we
sampled with replacement the Study ID numbers and included all
measurements associated with those IDs. The statistic of interest
was themeanof the absolute value of the differences. Wecollected
1000 sets of bootstrap samples of size 124 of the absolute value
of the differences for each parameter and we found the mean of
each of the 1000 sets. Thus, we have three clustered bootstrap
distributions of the mean of the absolute value of the differences.
Using each bootstrap distribution, we can calculate the mean,
standard error, and 95% confidence interval and compare the
results. Please see Table 3 for the results. Please see Figures 12
– 14 for the distributions of the mean of the absolute value of the
differences.
Based on the results, all parameters are significantly affected
by the exclusion of insulin. Sigma * SI has the smallest change in
values when including and excluding insulin, compared to sigma,
and SI. SI has the largest change when including and excluding
insulin. Thus, sigma * SI is more robust to the exclusion of insulin
than sigma and SI. SI is most affected by the exclusion of insulin.
Lastly, we wished to understand the direction of the
relationship between the parameters when including insulin. In
particular, we looked at the direction of the change in sigma *
SI, the direction of the change in sigma, and the direction of the
change in SI, when including and excluding insulin. Using the
original data, we calculated the means of each parameter, with
and without insulin. These means are displayed in Table 4. We
plotted a random sample of 50 OGTTs from the original data set.
We also plotted, in black, a line connecting the mean value for all
of the OGTTs for each parameter with insulin andwithout insulin.
These plots are displayed in Figures 15 – 17. In Figure 15, we
show the plot for sigma * SI. On average, there little change in
sigma * SI when including and excluding insulin, as displayed
by the flat slope of the line. In contrast, there are much larger
changes in sigma and changes in SI. In Figure 16, there is a large
positive change in sigma when removing insulin. In Figure 17,
✐✐
“main” — 2020/3/17 — 1:46 — page 8 — #8
✐
✐
✐
✐
✐
✐
8 Sample et al.
Fig. 12: Histogram of the Mean of the Absolute Value of the
Differences of SI
Fig. 13: Histogram of the Mean of the Absolute Value of the
Differences of SI
there is a large negative change in SI when removing insulin. The
steepness of the change for both sigma and SI are similar.
Fig. 14: Histogram of the Mean of the Absolute Value of the
Differences of SI
Parameter Mean With Insulin Mean Without Insulin
Sigma 1355.136 2039.622
SI 0.962 0.588
Sigma * SI 1111.803 1076.999
Table 4. Group Means for Each Parameter
5 Discussion
Data assimilation is a promising method that could be used in
healthcare to improve predictions. We applied data assimilation in
the context of Type 2 diabetes with the hope of using the method
to improve phenotyping. We have learned from the results that
the data assimilation method captures how well patients improve
glucose tolerance after their surgery. After a patient has a surgery,
there is a big jump in sigma * SI. In this way, the data assimilation
method captures information that doctors would not ordinarily
see. In addition, the sigma * SI values are more robust to the
exclusion of insulin than sigma and SI alone. Thus, even if insulin
measurements are not collected, which commonly occurs when
patients have an oral glucose tolerance test, doctors can still learn
information about a patient’s diabetic disease.
In the future, it would be interesting to analyze the patterns
of improvement in glucose tolerance as body mass index (BMI)
changes after surgery. It would also be interesting to see if we
could predict themeasurements of the nextOGTT.Lastly, itw
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Fig. 15: Change of Sigma * SI
Fig. 16: Change of Sigma
be interesting to run the data assimilation method in the cases of
missing glucose and insulin measurements.
Fig. 17: Change of SI
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Fig. 18: Scatterplot of Parameters and HbA1c by Year
Fig. 19: Scatterplot of Parameters and HbA1c by Year
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Fig. 20: Scatterplot of Parameters and HbA1c by Year
Fig. 21: Scatterplot of Parameters and HbA1c by Year
Fig. 22: Scatterplot of Parameters and HbA1c by Year
Fig. 23: Scatterplot of Parameters and HbA1c by Year
✐✐
“main” — 2020/3/17 — 1:46 — page 12 — #12
✐
✐
✐
✐
✐
✐
12 Sample et al.
Fig. 24: Scatterplot of Parameters and HbA1c by Year
Fig. 25: Scatterplot of Parameters and HbA1c by Year
Fig. 26: Scatterplot of Parameters and HbA1c by Year


